Tealwood Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Sell
21,047
-176
-0.8% -$15K 0.64% 78
2026
Q1
$1.83M Sell
21,223
-101
-0.5% -$9.06K 0.83% 53
2025
Q4
$1.86M Sell
21,324
-585
-3% -$44.4K 0.84% 52
2025
Q3
$1.25M Buy
21,909
+3,296
+18% +$190K 0.51% 101
2025
Q2
$1.1M Sell
18,613
-5
-0% -$323 0.49% 109
2025
Q1
$1.36M Sell
18,618
-496
-3% -$41K 0.63% 76
2024
Q4
$1.58M Buy
19,114
+48
+0.3% +$3.79K 0.65% 70
2024
Q3
$1.36M Buy
19,066
+53
+0.3% +$3.74K 0.6% 83
2024
Q2
$1.3M Sell
19,013
-6
-0% -$358 0.78% 66
2024
Q1
$1.02M Buy
+19,019
New +$1.02M 0.46% 111

Other funds holding GMED

Tealwood Asset Management's GMED Position: Q2 2026 in Review

Tealwood Asset Management reduced its Globus Medical (GMED) stake by 0.83% in Q2 2026, selling an estimated $15K and leaving 21,047 shares worth $1.66M. The position accounts for 0.64% of the portfolio, ranked #78.

Tealwood Asset Management first reported a position in GMED in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.86M in Q4 2025. 199 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Tealwood Asset Management held 21,047 shares of Globus Medical worth $1.66M as of Q2 2026.
  • Tealwood Asset Management sold 176 Globus Medical shares in Q2 2026, an estimated $15K.
  • Globus Medical made up 0.64% of Tealwood Asset Management's portfolio in Q2 2026, its #78 holding.
  • Tealwood Asset Management first reported a position in Globus Medical in Q1 2024 and has held it in 10 quarters since.
  • Tealwood Asset Management's Globus Medical position peaked at $1.86M in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Tealwood Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.